$BIIB Recent Headlines AT&T, Yelp shares decline after

New Post Public Reply Private Reply Replies (0) Message Board

Nov 3, 2014 at 11:57 AM

$BIIB Recent Headlines

AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares turn lower, down 2.7% premarket after Q3 results 8:13 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen beats estimates on strong MS drug sales 7:49 a.m. Oct. 22, 2014 - MarketWatch.com
Biogen shares rally after beating profit expectations, raising outlook 7:15 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares gain 0.7% premarket after Q3 results 7:06 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen ups full-year adj. EPS outlook to $13.45-$13.55 vs. FactSet estimate $13.10 7:05 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 net EPS $3.62 vs. $2.05 a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 FactSet sales consensus $2.48 bln 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 sales $2.51 bln vs. $1.83 bln a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 adj. EPS $3.80 vs. FactSet consensus $3.45 7:02 a.m. Oct. 22, 2014 - Tomi Kilgore
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
More than 1/3 of Dow stocks to report this week 5:30 a.m. Oct. 19, 2014 - Wallace Witkowski
NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
14 stocks loved by top-performing fund managers 6:49 a.m. Sept. 18, 2014 - Philip van Doorn

20 Stocks That Could Beat the Market in November 9:50 a.m. Today - TheStreet.com
Alkermes Incurs Wider Q3 Loss but Revenues Grow Y/Y - Analyst Blog 4:30 p.m. Oct. 31, 2014 - Zacks.com
Affymetrix Beats Q3 Earnings & Revenues; Raises '14 View - Analyst Blog 3:30 p.m. Oct. 31, 2014 - Zacks.com
Incyte Gains on Q3 Earnings and Revenue Beat, Raises View - Analyst Blog 1:49 p.m. Oct. 31, 2014 - Zacks.com
Acorda (ACOR) Beats on Q3 Earnings, Ups Ampyra Outlook - Analyst Blog 1:20 p.m. Oct. 31, 2014 - Zacks.com
AMAG Up on Q3 Earnings Beat, Revenues Up - Analyst Blog 10:57 a.m. Oct. 31, 2014 - Zacks.com
Today's Momo Momentum Stock To Watch: Biogen Idec (BIIB) 9:50 a.m. Oct. 31, 2014 - TheStreet.com
Incyte (INCY) Looks Good: Stock Moves 10.9% Higher - Tale of the Tape 9:46 a.m. Oct. 31, 2014 - Zacks.com
BIND Therapeutics, Inc. (BIND) Surges: Stock Rises 14.2% Higher - Tale of the Tape 9:11 a.m. Oct. 31, 2014 - Zacks.com
Jim Cramer's Top Stock Picks: CELG REGN GILD BIIB TTWO CRL FLEX 6:00 a.m. Oct. 31, 2014 - TheStreet.com
Cramer's Mad Money - Charles River Labs Battles Ebola (10/30/14) 5:46 a.m. Oct. 31, 2014 - Seeking Alpha
Jim Cramer's 'Mad Money' Recap: Here's Why the Bears Were Dead Wrong 8:11 p.m. Oct. 30, 2014 - TheStreet.com
Qiagen Q3 Earnings, Revenues in Line; Outlook Revised - Analyst Blog 2:50 p.m. Oct. 30, 2014 - Zacks.com
Oncolytics Biotech (ONCY) Looks Good: Stock Soars 26% - Tale of the Tape 9:25 a.m. Oct. 30, 2014 - Zacks.com
Buy These Top Ranked ETFs on Solid Biotech Stock Earnings - ETF News And Commentary 8:00 a.m. Oct. 30, 2014 - Zacks.com
Amgen Up on Strategic Initiatives and 2015 Guidance - Analyst Blog 3:05 p.m. Oct. 29, 2014 - Zacks.com
Ligand Pharmaceuticals' Shares Fall on Q3 Earnings Miss - Analyst Blog 2:00 p.m. Oct. 29, 2014 - Zacks.com
Vertex Pharmaceuticals Posts Narrower-than-Expected Loss - Analyst Blog 1:00 p.m. Oct. 29, 2014 - Zacks.com
Biotech Stock Roundup: Beat & Raise Quarter for Amgen, Celgene, Alexion, Biogen - Analyst Blog 12:28 p.m. Oct. 29, 2014 - Zacks.com
One More Time: The Genzyme Contingent Value Right 10:15 a.m. Oct. 29, 2014 - Seeking Alpha

3D Bioprinting Technology Developed by RBCC Partner n3D Biosciences Helps Researchers Create a Better In Vitro Breast Cancer Model 5:30 a.m. Today - BusinessWire - BZX
Biogen Idec and Sobi announce European Medicines Agency validates Elocta(TM) (rFVIIIFc) Marketing Authorisation Application for review 4:10 p.m. Oct. 31, 2014 - Thomson Reuters ONE
Biogen Idec and Sobi Announce European Medicines Agency Validates ELOCTA™ (rFVIIIFc) Marketing Authorization Application for Review 4:05 p.m. Oct. 31, 2014 - BusinessWire - BZX
Quarterly Earnings Releases, Technical Updates, Software Launches, Welfare Initiatives, and New Health Plans - Research Reports on Biogen, Express Scripts, Covidien, Alexion and Aetna 8:45 a.m. Oct. 30, 2014 - PR Newswire - PRF
Market Movers - Biotech Stocks -- NewLink Genetics, Biogen Idec, United Therapeutics, Dynavax Technologies, and Amarin 8:40 a.m. Oct. 29, 2014 - PR Newswire - PRF
Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases 7:30 a.m. Oct. 23, 2014 - BusinessWire - BZX
Regulatory Approval, Customer Safety Alert, Patient Support Program Launch, Earnings Releases, and Rating - Research Reports on Medtronic, Covidien, Biogen Idec, Baxter and Express Scripts 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals 8:01 a.m. Oct. 15, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
Sobi's collaboration partner Biogen Idec files marketing authorisation application for Elocta(TM) (rFVIIIFc) in Europe 3:01 p.m. Oct. 9, 2014 - Thomson Reuters ONE
CORRECTING and REPLACING Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 4:01 p.m. Oct. 8, 2014 - BusinessWire - BZX
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 5:34 p.m. Sept. 25, 2014 - BusinessWire - BZX
Results of Clinical Trials, New Drug Applications, Leadership Appointments, and Scheduled Earnings - Research Reports on Biogen, Salix, Express Scripts, Stryker and Shire 9:25 a.m. Sept. 23, 2014 - PR Newswire - PRF
Biogen Idec Named Global Biotechnology Industry Leader on Dow Jones Sustainability World Index 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy 7:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Sobi expands Haemophilia development portfolio - elects to include potentially longer-acting Haemophilia A candidate in collaboration agreement with Biogen Idec 2:01 a.m. Sept. 19, 2014 - Thomson Reuters ONE
Ignyta to Participate in Precision Medicine Panel Discussions with Other Thought Leaders 7:00 a.m. Sept. 17, 2014 - BusinessWire - BZX
Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire 8:50 a.m. Sept. 15, 2014 - PR Newswire - PRF
Health Care Sector Stocks Technical Review - Ampio Pharma, InterMune, Biogen Idec, Hologic, and CareFusion Corp. 8:40 a.m. Sept. 15, 2014 - PR Newswire - PRF

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Changhong's IFA 2026 Showcase: AI, Culture & Localization

Changhong's Game Plan: From Global Reach to Local Touch Well, Changhong's not sitting back at IFA 2026, let me tell you that. This isn't your run-of-the-mill showcase; it's a full-on reveal of what happens when a company takes AI tech and tunes it to the heartbeat of daily life. TVs, fridges, air conditioners—you name it, they've got an AI twist on it. But is this just...

Roborock Fuels Market Surge with 27.6% Revenue Boost

Roborock's Rocket-Like Ascent in Global Markets Call me impressed, but Roborock is really hitting its stride. The company's been on a tear, pulling in RMB 10.084 billion during the first half of 2026—a remarkable 27.6% bump from last year. Not just content with the revenue surge, they also saw net profits jump 45.6%, making it pretty clear that they're not just playing...

Hims & Hers Faces Class Action: Investors Beware

Allegations and Legal Pressure There's trouble brewing in the land of health and wellness apps, with Hims & Hers Health, Inc. (NYSE:HIMS) taking center stage. Slap on your glasses, folks, because this one's a doozy. A class-action lawsuit has exploded against the company and some of its officers—allegations flying as they focus on serious accusations of misleading...

Pudu D7 Robot Shines at IFA, Setting New Robotics Bar

Breaking New Ground in Robotics at IFA Well, here's a nugget for robotics buffs and investors alike: Pudu Robotics, a heavyweight in commercial service robotics, is carving out a fresh chapter with its PUDU D7. Making waves as an honoree at the IFA Innovation Awards, the D7 presents a mash-up of brains and brawn—exemplifying the future path for robotics. The PUDU D7...

Midea's VitaBreeze: Revolutionizing Personalized Climate

A Fresh Breeze in Climate Control Here's something that'll shake up your household. Midea just announced their latest gizmo, called VitaBreeze, and they’re not messing around. They introduced it at IFA 2026, promising it's not just for cooling off in the summer or heating in the winter. Oh no, my friends, they've packed this unit with enough cutting-edge tech that...

Bad Bunny Super Bowl Halftime Show Sweeps 7 Emmy Wins

An Unprecedented Performance: A Halftime Show for the Ages Hold onto your hats, folks—Bad Bunny and his Super Bowl LX Halftime Show have taken home a jaw-dropping seven Emmys at the 78th Emmy Awards. This is uncharted territory for any Super Bowl Halftime Show. Never before has a halftime spectacle swept the Emmys like this. We’re talking about categories such as...

York Space Systems Faces Class Action Over Misleading IPO

York Space Systems Under the Legal Spotlight Ever get that feeling when something just doesn’t sit right? Like a burr under the saddle, York Space Systems is now grappling with a class action lawsuit that's throwing a heap of shade on its recent moves. What’s at play? Bronstein, Gewirtz & Grossman, LLC, a law firm that seems to have a nose for corporate messes, has...

MERACH Unveils W60 Plus: A Game Changer for Home Fitness

MERACH's Ambitious Leap into European Markets Walking is one of life's simple pleasures, but it's not always convenient in our work-from-home driven world. That's where MERACH's UltraWalk W60 Plus comes in, dropping anchor in Europe like a brand new ship with all the bells and whistles. What makes this walking pad different, you ask? It's designed to become a natural...

TCL’s AI Vision: Immersive Living at IFA 2026

AI and Displays: A Match Made in Tech Heaven Every so often, a company stands up at a tech fair and gives a glimpse into the next chapter of living, as TCL did at IFA 2026. This time, they're not just talking about screens; they're weaving them into the fabric of everyday life alongside AI capabilities. From sporting arenas to your living room, it's a vision of what could...

Creality Rolls Out K3, SPARKX i8 at IFA 2026

Creality Struts Its Stuff at IFA 2026 You wouldn't guess 3D printing had anything left to dazzle us with, but Creality has sure put those notions to rest at the IFA 2026 in Berlin. They're rolling out the big guns with fresh tech that pushes both efficiency and sustainability—two big buzzwords these days—and ties a neat little bow on their innovative streak....